BostonSight | Strategic Alliance Partners

Shorts

0:39

AI in ophthalmology isn’t just future-facing; it’s already in the front office

16 days ago

Latest from BostonSight

BostonSight publishes pilot study on PROSE scleral lenses as a drug delivery system for cyclosporine in dry eye treatment

ByDavid Hutton

December 6th 2024

BostonSight’s pilot study, published in Clinical Ophthalmology, explores the use of PROSE scleral lenses as a drug delivery system for cyclosporine 0.05% in treating dry eye disease, showing promising symptom relief and tolerability.